Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Natera

Biotech & Life Sciences · Austin, United States · Founded 2004 · IPO 2015 Decacorn

Harnessing the power of DNA to improve the management of reproductive health, cancer, and organ transplants

Valuation
$27B
Market cap · May/2026
Revenue
$2.30B
Latest reported FY

Investors

13 investors on Natera's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 2 investors entered at this stage
Claremont Creek Ventures
Sequoia
Series B+ 11 investors entered at this stage

Global footprint

Where Natera has talent and traffic

AI talent share
1.4% of workforce is AI talent
(81 of 5,669 staff)
Core AI250.44%
Other AI560.99%
Non-AI workforce5,58898.57%
Workforce by country
40 countries with
team presence
🇺🇸 United States95.4%
🇷🇸 Serbia1.7%
🇷🇺 Russia0.6%
🇨🇦 Canada0.3%
🇬🇹 Guatemala0.2%
Top 5 of 40 shown
Web traffic by country
1.1M monthly visits
across markets
🇺🇸 United States92.4%
🇩🇪 Germany0.9%
🇨🇦 Canada0.4%
🏳️ Korea0.3%
🏳️ Republic of0.3%
Top 5 markets shown

Patent intelligence

$71M patent portfolio · 59 active families

Estimated portfolio value
$71M
0.26% of market cap · 1.5× smaller than top peer Resilience ($108M)
59 active patent families
Where Natera innovates CellBioinformaticsMedicineNucleic acidComputational biology

Where Natera concentrates vs peers

Each axis is a top-10 topic across Natera and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

Natera's 2 investments and acquisitions.

Every disclosed deal where Natera appeared as a backer or acquirer, 2022–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

2 deals across Natera's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        01 · Deployment strategy vs peers

        Where Natera deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        02 · Portfolio market map

        Natera's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        2 of 2 deals

        Market sentiment

        What the market is saying about Natera

        An AI-synthesized read of the highest-engagement posts about Natera on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Natera on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.